Medtronic plc. Ordinary Shares (MDT): Price and Financial Metrics
Medtronic plc. Ordinary Shares (MDT)
Today's Latest Price: $93.16 USD
Updated Jul 2 7:00pm
Add MDT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 132 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
MDT Stock Summary
- Medtronic plc's market capitalization of $122,997,107,479 is ahead of 98.68% of US-listed equities.
- Medtronic plc's stock had its IPO on January 1, 1986, making it an older stock than 92.91% of US equities in our set.
- In terms of volatility of its share price, MDT is more volatile than only 11.05% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Medtronic plc, a group of peers worth examining would be DHR, TMUS, SNY, GSK, and UNP.
- MDT's SEC filings can be seen here. And to visit Medtronic plc's official web site, go to www.medtronic.com.
MDT Stock Price Chart Technical Analysis Charts
MDT Price/Volume Stats
| Current price | $93.16 | 52-week high | $122.15 |
| Prev. close | $92.32 | 52-week low | $72.13 |
| Day low | $92.96 | Volume | 3,937,913 |
| Day high | $94.41 | Avg. volume | 6,583,744 |
| 50-day MA | $95.78 | Dividend yield | 2.49% |
| 200-day MA | $104.15 | Market Cap | 124.96B |
Medtronic plc. Ordinary Shares (MDT) Company Bio
Medtronic plc manufactures and sells device-based medical therapies worldwide. The company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The company was founded in 1949 and is based in Dublin, Ireland.
MDT Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $93.16 | $60.62 | -32% |
Below please find a table outlining a discounted cash flow forecast for MDT, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Medtronic plc ranked in the 38th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for MDT, they are:
- Medtronic plc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than merely 0% of US stocks with positive free cash flow.
- The weighted average cost of capital for the company is 7. This value is greater than just 22.98% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -33% |
| 1% | -32% |
| 2% | -32% |
| 3% | -31% |
| 4% | -30% |
| 5% | -30% |
BDX, NVS, HRC, USPH, and LCI can be thought of as valuation peers to MDT, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...